Mercato chiuso -
Altri mercati azionari
|
Variaz. 5gg | Var. 1 gen. | ||
445,2 USD | +1,04% | +5,31% | +9,42% |
15/05 | Vertex Pharmaceuticals Incorporated nomina Jennifer Schneider come direttore indipendente | CI |
14/05 | VERTEX PHARMACEUTICALS INCORPORATED : Wolfe Research rimane Buy | ZM |
Pubblicazioni ufficiali
Slide show Q1 | CO | |
1st quarter results | CO | |
SEC Filing 8K | CO | |
SEC Filing 10K | CO | |
SEC Filing 13G | CO | |
SEC Filing 13G | CO | |
Slide show results | CO | |
Annual results | CO | |
SEC Filing 8K | CO | |
SEC Filing 8K | CO | |
SEC Filing 10Q-3 | CO | |
Slide show Q3 | CO | |
3rd quarter results | CO | |
SEC Filing 8K | CO | |
SEC Filing 10Q-2 | CO | |
Slide show half-year results | CO | |
1st-half-year results | CO | |
SEC Filing 8K | CO | |
SEC Filing 10Q-1 | CO | |
Slide show Q1 | CO | |
1st quarter results | CO | |
SEC Filing 8K | CO | |
SEC Filing 13G | CO | |
SEC Filing 10K | CO | |
SEC Filing 13G | CO |
- Borsa valori
- Azioni
- Azione VRTX
- Notizie Vertex Pharmaceuticals Incorporated
- Pubblicazioni ufficiali